𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and efficacy of rituximad to treat systemic lupus erythematosus in children

✍ Scribed by Emma Jane MacDermott; Thomas J. A. Lehman

Book ID
107553852
Publisher
Springer
Year
2006
Tongue
English
Weight
49 KB
Volume
8
Category
Article
ISSN
1523-3774

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and safety of rituximab in mode
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
✍ Joan T. Merrill; C. Michael Neuwelt; Daniel J. Wallace; Joseph C. Shanahan; Kevi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 499 KB πŸ‘ 2 views

## Abstract ## Objective B cells are likely to contribute to the pathogenesis of systemic lupus erythematosus (SLE), and rituximab induces depletion of B cells. The Exploratory Phase II/III SLE Evaluation of Rituximab (EXPLORER) trial tested the efficacy and safety of rituximab versus placebo in p

Use of atorvastatin in systemic lupus er
Use of atorvastatin in systemic lupus erythematosus in children and adolescents
✍ L. E. Schanberg; C. Sandborg; H. X. Barnhart; S. P. Ardoin; E. Yow; G. W. Evans; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 197 KB πŸ‘ 2 views

## Abstract ## Objective Statins reduce atherosclerosis and cardiovascular morbidity in the general population, but their efficacy and safety in children and adolescents with systemic lupus erythematosus (SLE) are unknown. This study was undertaken to determine the 3‐year efficacy and safety of at